ATE295177T1 - Dipeptid kaspase inhibitoren und deren verwendung - Google Patents
Dipeptid kaspase inhibitoren und deren verwendungInfo
- Publication number
- ATE295177T1 ATE295177T1 AT99912579T AT99912579T ATE295177T1 AT E295177 T1 ATE295177 T1 AT E295177T1 AT 99912579 T AT99912579 T AT 99912579T AT 99912579 T AT99912579 T AT 99912579T AT E295177 T1 ATE295177 T1 AT E295177T1
- Authority
- AT
- Austria
- Prior art keywords
- inhibitors
- kaspase
- dipeptide
- cell death
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7805198P | 1998-03-16 | 1998-03-16 | |
PCT/US1999/005729 WO1999047154A1 (en) | 1998-03-16 | 1999-03-16 | Dipeptide caspase inhibitors and the use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE295177T1 true ATE295177T1 (de) | 2005-05-15 |
Family
ID=22141618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99912579T ATE295177T1 (de) | 1998-03-16 | 1999-03-16 | Dipeptid kaspase inhibitoren und deren verwendung |
Country Status (10)
Country | Link |
---|---|
US (1) | US6153591A (de) |
EP (1) | EP1076563B1 (de) |
JP (1) | JP2002506829A (de) |
KR (1) | KR20010041905A (de) |
CN (1) | CN1297354A (de) |
AT (1) | ATE295177T1 (de) |
AU (1) | AU755273B2 (de) |
CA (1) | CA2323439A1 (de) |
DE (1) | DE69925268T2 (de) |
WO (1) | WO1999047154A1 (de) |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6184210B1 (en) * | 1997-10-10 | 2001-02-06 | Cytovia, Inc. | Dipeptide apoptosis inhibitors and the use thereof |
US6319955B1 (en) * | 1998-01-06 | 2001-11-20 | The General Hospital Corporation | Use of MEK1 inhibitors as protective agents against damage due to ischemia |
US6675173B1 (en) * | 1998-01-22 | 2004-01-06 | Ori Software Development Ltd. | Database apparatus |
WO2000004914A1 (en) * | 1998-07-21 | 2000-02-03 | Cytovia, Inc. | Novel fluorescence dyes and their applications for whole cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof |
EP1165490B1 (de) | 1999-03-16 | 2006-08-16 | Cytovia, Inc. | Substituierte 2-aminobenzamin caspase inhibitoren und ihre verwendung |
WO2000061542A1 (en) | 1999-04-09 | 2000-10-19 | Cytovia, Inc. | Caspase inhibitors and the use thereof |
IL148426A0 (en) | 1999-08-27 | 2002-09-12 | Cytovia Inc | α-HYDROXY ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
KR100399361B1 (ko) * | 1999-11-04 | 2003-09-26 | 주식회사 엘지생명과학 | 캐스파제 억제제 함유 치료제 조성물 |
AU7127600A (en) * | 1999-09-17 | 2001-04-17 | Basf Aktiengesellschaft | Methods and compositions for modulating responsiveness to corticosteroids |
US6566338B1 (en) * | 1999-10-12 | 2003-05-20 | Cytovia, Inc. | Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death |
WO2001027085A1 (en) * | 1999-10-13 | 2001-04-19 | Merck Frosst Canada & Co. | Nicotinyl aspartyl ketones as inhibitors of caspase-3 |
AU1920501A (en) * | 1999-12-03 | 2001-06-12 | Alcon Universal Limited | The use of caspase 9 inhibitors to treat ocular neural pathology |
WO2001045716A1 (en) * | 1999-12-20 | 2001-06-28 | Gho'st Holding B.V. | Pharmaceutical composition comprising a physiologically acceptable vanadium compound, salt or complex and a na+/h+ exchange inhibitor |
DE10006889A1 (de) * | 2000-02-16 | 2001-09-06 | Procorde Gmbh | Verwendung von Inhibitoren von Caspase-3 oder der Caspase-aktivierten Desoxyribonuclease (CAD) zur Behandlung von Herzerkrankungen |
EP1923386A3 (de) | 2000-03-29 | 2008-05-28 | Vertex Pharmceuticals Incorporated | Carbamatderivate als Caspaseinhibitoren und Verwendung davon |
ATE384695T1 (de) | 2000-03-29 | 2008-02-15 | Vertex Pharma | Carbamat caspase inhibitoren und deren verwendung |
EP1283827A2 (de) | 2000-05-23 | 2003-02-19 | Vertex Pharmaceuticals Incorporated | Caspase inhibitoren und deren verwendung |
AU2001268255A1 (en) | 2000-06-05 | 2001-12-17 | The Burnham Institute | Methods of differentiating and protecting cells by modulating the p38/mef2 pathway |
US6800619B2 (en) | 2000-09-13 | 2004-10-05 | Vertex Pharmaceuticals Incorporated | Caspase inhibitors and uses thereof |
US6660731B2 (en) | 2000-09-15 | 2003-12-09 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
EP1317450B1 (de) | 2000-09-15 | 2006-11-22 | Vertex Pharmaceuticals Incorporated | Pyrazolverbindungen als protein-kinasehemmer |
WO2002048179A1 (en) * | 2000-12-15 | 2002-06-20 | Merck Frosst Canada & Co. | Gamma-ketoacid dipeptide derivatives as inhibitors of caspase-3 |
NZ526471A (en) | 2000-12-21 | 2005-08-26 | Vertex Pharma | Pyrazole compounds useful as protein kinase inhibitors |
WO2002076939A2 (en) * | 2001-02-05 | 2002-10-03 | Exegenics Inc. | Cysteine protease inhibitors |
US6804677B2 (en) * | 2001-02-26 | 2004-10-12 | Ori Software Development Ltd. | Encoding semi-structured data for efficient search and browsing |
US7411000B2 (en) * | 2001-03-15 | 2008-08-12 | The Scripps Research Institute | Process of inhibiting cell death in injured cartilage |
EP1381602A1 (de) | 2001-04-19 | 2004-01-21 | Vertex Pharmaceuticals Incorporated | Heterocyclylbiscarbonsäureamide als caspasehemmer |
US7527938B2 (en) * | 2001-06-19 | 2009-05-05 | R.E.D. Laboratories N.V./S.A. | Methods for diagnosis and treatment of chronic immune diseases |
US6989239B2 (en) * | 2001-06-20 | 2006-01-24 | R.E.D. Laboratories, N.V./S.A. | Methods for diagnosis and treatment of chronic immune diseases |
DE122010000047I1 (de) | 2001-06-26 | 2011-05-05 | Amgen Fremont Inc | Antikörper gegen opgl |
US7287033B2 (en) | 2002-03-06 | 2007-10-23 | Ori Software Development, Ltd. | Efficient traversals over hierarchical data and indexing semistructured data |
NI200300043A (es) | 2002-03-28 | 2003-11-05 | Warner Lambert Co | AMINOACIDOS CON AFINIDAD POR LA PROTEINA a2DELTA. |
WO2004002401A2 (en) * | 2002-04-05 | 2004-01-08 | Cytovia, Inc. | Caspase inhibitors for the treatment of diseases and conditions caused by exposure to radionuclides, biological agents, or chemical agents |
AU2003224482A1 (en) | 2002-04-30 | 2003-11-17 | Korea Research Institute Of Chemical Technology | Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same |
AU2003238948A1 (en) * | 2002-06-05 | 2003-12-22 | Sunesis Pharmaceuticals, Inc. | Caspase-1 inhibitors and methods for their use |
MY141867A (en) | 2002-06-20 | 2010-07-16 | Vertex Pharma | Substituted pyrimidines useful as protein kinase inhibitors |
US7195884B2 (en) * | 2002-07-19 | 2007-03-27 | Promega Corp. | Methods and kits for transferases |
PT1532145E (pt) | 2002-08-02 | 2007-01-31 | Vertex Pharma | Composiçoes de pirazole úteis como inibidores de gsk-3 |
CN100471871C (zh) | 2002-09-06 | 2009-03-25 | 安姆根有限公司 | 治疗性人抗-il-1r1单克隆抗体 |
US7361339B2 (en) * | 2003-01-09 | 2008-04-22 | Alexion Pharmaceuticals, Inc. | Methods for reducing morality associated with acute myocardial infarction |
US7504382B2 (en) * | 2003-05-06 | 2009-03-17 | Cytovia, Inc. | Protease inhibitors for coronaviruses and SARS-CoV and the use thereof |
US8790637B2 (en) | 2003-06-27 | 2014-07-29 | DePuy Synthes Products, LLC | Repair and regeneration of ocular tissue using postpartum-derived cells |
EP1641915B1 (de) | 2003-06-27 | 2016-07-27 | DePuy Synthes Products, Inc. | Reparatur und regenerierung von augengewebe mit postpartum abgeleiteten zellen |
NZ546504A (en) * | 2003-10-24 | 2009-01-31 | Aventis Pharma Inc | Novel keto-oxadiazole derivatives as cathepsin inhibitors |
NZ588448A (en) | 2004-05-15 | 2012-01-12 | Vertex Pharma | Treating seizures using interleukin-1beta converting enzyme (ICE) inhibitors |
US7531570B2 (en) | 2004-05-27 | 2009-05-12 | Vertex Pharmaceuticals Incorporated | Treatment of diseases using ICE inhibitors |
JP5340599B2 (ja) | 2004-12-23 | 2013-11-13 | エシコン・インコーポレイテッド | 臍帯組織由来産褥細胞ならびにその製造方法および使用方法 |
EP1946101A4 (de) * | 2005-10-21 | 2011-08-10 | Immunochemistry Technologies Llc | In-vivo-apoptosenachweis |
CA2627857A1 (en) | 2005-11-03 | 2007-05-18 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as kinase inhibitors |
TW200736277A (en) | 2005-11-14 | 2007-10-01 | Amgen Inc | RANKL antibody-PTH/PTHrP chimeric molecules |
WO2007073552A1 (en) | 2005-12-19 | 2007-06-28 | Ethicon, Inc. | In vitro expansion of postpartum derived cells in roller bottles |
KR101299720B1 (ko) * | 2006-08-16 | 2013-08-28 | 주식회사 엘지생명과학 | 3-아미노-5-플루오로-4-디알콕시펜탄산 에스테르의 새로운제조방법 |
JP5389785B2 (ja) | 2007-05-02 | 2014-01-15 | バーテックス ファーマシューティカルズ インコーポレイテッド | キナーゼ阻害剤として有用なチアゾールおよびピラゾール |
CA2694499A1 (en) | 2007-07-31 | 2009-02-05 | Vertex Pharmaceuticals Incorporated | Process for preparing 5-fluoro-1h-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof |
US8236538B2 (en) | 2007-12-20 | 2012-08-07 | Advanced Technologies And Regenerative Medicine, Llc | Methods for sterilizing materials containing biologically active agents |
EP2323622A1 (de) | 2008-09-03 | 2011-05-25 | Vertex Pharmaceuticals Incorporated | Co-kristalle und diese enthaltende pharmazeutische formulierungen |
US10179900B2 (en) | 2008-12-19 | 2019-01-15 | DePuy Synthes Products, Inc. | Conditioned media and methods of making a conditioned media |
US20120219596A1 (en) | 2009-07-30 | 2012-08-30 | Wendelin Stark | Injectable formulation for treatment and protection of patients having an inflammatory reaction or an ischemia-reperfusion event |
WO2012061785A2 (en) | 2010-11-05 | 2012-05-10 | Brandeis University | Ice inhibiting compounds and uses thereof |
WO2012085279A2 (en) * | 2010-12-23 | 2012-06-28 | Universiteit Gent | Method for cross-linking peptides |
JP6219928B2 (ja) * | 2012-04-18 | 2017-10-25 | リパブリック・オブ・コリア(マネジメント:ルーラル・デベロップメント・アドミニストレーション)Republic Of Korea (Management Rural Development Administration) | 農業用作物保護剤の製造方法 |
AU2019233195A1 (en) * | 2018-03-13 | 2020-09-24 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | A crystal of a caspase inhibitor |
WO2020035482A1 (en) | 2018-08-13 | 2020-02-20 | Iltoo Pharma | Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereof |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2381023A1 (fr) * | 1977-02-18 | 1978-09-15 | Delalande Sa | Nouveaux oligopeptides trifluoromethyles derives de la l-alanine, leur procede de preparation et leur application en therapeutique |
US4518528A (en) * | 1983-05-19 | 1985-05-21 | Rasnick David W | α Amino fluoro ketones |
US5416013A (en) * | 1990-04-04 | 1995-05-16 | Sterling Winthrop Inc. | Interleukin 1β protease and interleukin 1β protease inhibitors |
DE69226820T2 (de) * | 1991-06-21 | 1999-05-12 | Merck & Co Inc | Peptidylderivate als Inhibitoren von Interleukin-1B-konvertierenden Enzymen |
ATE257517T1 (de) * | 1991-08-30 | 2004-01-15 | Vertex Pharma | Interleukin 1-beta protease und ihre inhibitoren |
ES2118940T3 (es) * | 1992-02-21 | 1998-10-01 | Merck & Co Inc | Peptidil-derivados utiles como inhibidores de la enzima conversora de la interleucina-1 beta. |
EP0618223A3 (de) * | 1993-03-08 | 1996-06-12 | Sandoz Ltd | Peptide, die Freisetzung vom Interleukin 1-Bêta, nützlich als entzündungshemmende Wirkstoffe. |
US5462939A (en) * | 1993-05-07 | 1995-10-31 | Sterling Winthrop Inc. | Peptidic ketones as interleukin-1β-converting enzyme inhibitors |
JPH0789951A (ja) * | 1993-06-03 | 1995-04-04 | Sterling Winthrop Inc | インターロイキン−1β転換酵素阻害剤 |
US6087160A (en) * | 1993-06-24 | 2000-07-11 | The General Hospital Corporation | Programmed cell death genes and proteins |
WO1995005192A1 (en) * | 1993-08-13 | 1995-02-23 | Merck & Co., Inc. | SUBSTITUTED KETONE DERIVATIVES AS INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
US5565430A (en) * | 1994-08-02 | 1996-10-15 | Sterling Winthrop Inc. | Azaaspartic acid analogs as interleukin-1β converting enzyme inhibitors |
GB9509888D0 (en) * | 1995-05-16 | 1995-07-12 | Pharmacia Spa | Terpenoidic derivatives useful as antitumour agents |
US5744451A (en) * | 1995-09-12 | 1998-04-28 | Warner-Lambert Company | N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity |
US5843904A (en) * | 1995-12-20 | 1998-12-01 | Vertex Pharmaceuticals, Inc. | Inhibitors of interleukin-1βconverting enzyme |
US5869519A (en) * | 1996-12-16 | 1999-02-09 | Idun Pharmaceuticals, Inc. | C-terminal modified (n-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
EP0874850B1 (de) * | 1996-09-12 | 2002-04-10 | Idun Pharmaceuticals, Inc. | Neue tricyclische verbindungen mit ice/ced-3 protease familie-hemmenden eigenschaften |
AU738048B2 (en) * | 1996-09-12 | 2001-09-06 | Idun Pharmaceuticals, Inc. | Inhibition of apoptosis using interleukin-1beta-converting enzyme (ICE)/CED-3 family inhibitors |
EP0998300A1 (de) * | 1997-03-18 | 2000-05-10 | Basf Aktiengesellschaft | Zusammensetzungen zur modulation der empfänglichkeit für corticosteroiden |
AU741203B2 (en) * | 1997-10-10 | 2001-11-22 | Cytovia, Inc. | Dipeptide apoptosis inhibitors and the use thereof |
-
1999
- 1999-03-16 US US09/270,735 patent/US6153591A/en not_active Expired - Lifetime
- 1999-03-16 KR KR1020007010209A patent/KR20010041905A/ko not_active Application Discontinuation
- 1999-03-16 DE DE69925268T patent/DE69925268T2/de not_active Expired - Fee Related
- 1999-03-16 CN CN99805211A patent/CN1297354A/zh active Pending
- 1999-03-16 JP JP2000536394A patent/JP2002506829A/ja not_active Withdrawn
- 1999-03-16 EP EP99912579A patent/EP1076563B1/de not_active Expired - Lifetime
- 1999-03-16 AT AT99912579T patent/ATE295177T1/de not_active IP Right Cessation
- 1999-03-16 WO PCT/US1999/005729 patent/WO1999047154A1/en not_active Application Discontinuation
- 1999-03-16 CA CA002323439A patent/CA2323439A1/en not_active Abandoned
- 1999-03-16 AU AU30925/99A patent/AU755273B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
EP1076563A1 (de) | 2001-02-21 |
KR20010041905A (ko) | 2001-05-25 |
JP2002506829A (ja) | 2002-03-05 |
DE69925268T2 (de) | 2006-03-23 |
US6153591A (en) | 2000-11-28 |
CA2323439A1 (en) | 1999-09-23 |
AU755273B2 (en) | 2002-12-05 |
EP1076563A4 (de) | 2003-04-23 |
CN1297354A (zh) | 2001-05-30 |
AU3092599A (en) | 1999-10-11 |
DE69925268D1 (de) | 2005-06-16 |
EP1076563B1 (de) | 2005-05-11 |
WO1999047154A1 (en) | 1999-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE295177T1 (de) | Dipeptid kaspase inhibitoren und deren verwendung | |
ATE363465T1 (de) | Caspase inhibitoren und ihre verwendung | |
ATE336480T1 (de) | Substituierte 2-aminobenzamin caspase inhibitoren und ihre verwendung | |
NO20020938D0 (no) | Substituerte alfa-hydroksysyre-caspaseinhibitorer og deres anvendelse | |
BR9814817A (pt) | Inibidores de apoptose de dipeptìdio e o uso dos mesmos | |
DE122006000014I2 (de) | Pyranonverbindungen zur Behandlung retroviraler Infektionen | |
DK1485359T3 (da) | Natriumkanalblokkere | |
NO992821L (no) | Ketobenzamider som calpain-inhibitorer | |
TR200201144T2 (tr) | NFKB aktivitesinin modülasyonu için ikame edilmiş indoller | |
MY138140A (en) | N-aroylphenylalanine derivatives | |
TR200100189T2 (tr) | Hücre yapışması engelleyici iltihaplanmaya karşı bileşikler | |
HUP0004592A2 (hu) | VCAM-1 expresszió gátlására alkalmas vegyületek és eljárások | |
NO963370D0 (no) | Nye mercaptoacetylamido-1,3,4,5-tetrahydro-benzo[cÅazepin-3-on-disulfidderivater som er anvendbare som inhibitorer av enkefalinase og ACE | |
DK0773955T3 (da) | Hidtil ukendte inhibitorer for thrombin, deres fremstilling og anvendelse | |
ATE309237T1 (de) | Aromatische heterozyklische verbindungen als antientzündungwirkstoffe | |
EA200200253A1 (ru) | Ингибиторы клеточной адгезии | |
DK1124842T3 (da) | Betulinsyrederivater anvendelige til behandling af neuroektodermale tumorer | |
TR200401209T4 (tr) | Kaspazların aktivatörleri ve apoptoz endüserleri olarak yer değiştiren 4H-kromen ve analogları ile bunların kullanımı | |
DE59902779D1 (de) | Kristallmodifikation der liponsäure | |
EA200000204A1 (ru) | Производные пирролопирролона в качестве ингибиторов эластазы нейтрофилов | |
AR025951A1 (es) | Derivados de 4-hicroxibifenil hidrazidas y métodos para preparar los derivados. | |
TR200001909T2 (tr) | Matris metaloprotez inhibitörleri. | |
NO983444L (no) | Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer | |
WO1999065451A3 (en) | Caspases and apoptosis | |
DE60131968D1 (de) | PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |